1. Home
  2. BYND vs ARMP Comparison

BYND vs ARMP Comparison

Compare BYND & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$0.71

Market Cap

346.2M

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$8.00

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYND
ARMP
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.2M
383.7M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
BYND
ARMP
Price
$0.71
$8.00
Analyst Decision
Sell
Strong Buy
Analyst Count
7
2
Target Price
$1.70
$15.00
AVG Volume (30 Days)
30.2M
41.3K
Earning Date
05-06-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
53.80
53.40
EPS
N/A
N/A
Revenue
$326,452,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.90
52 Week High
$7.69
$13.75

Technical Indicators

Market Signals
Indicator
BYND
ARMP
Relative Strength Index (RSI) 43.28 38.88
Support Level $0.67 $5.14
Resistance Level $0.82 $8.40
Average True Range (ATR) 0.06 0.94
MACD -0.00 -0.46
Stochastic Oscillator 9.80 6.30

Price Performance

Historical Comparison
BYND
ARMP

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: